Bellevue Group AG Has $37.97 Million Stock Position in HCA Healthcare, Inc. $HCA

Bellevue Group AG lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 60.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 99,122 shares of the company’s stock after acquiring an additional 37,315 shares during the period. Bellevue Group AG’s holdings in HCA Healthcare were worth $37,974,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank acquired a new position in shares of HCA Healthcare during the second quarter worth about $1,152,408,000. Price T Rowe Associates Inc. MD grew its stake in shares of HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after acquiring an additional 1,091,416 shares in the last quarter. Viking Global Investors LP lifted its position in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Nordea Investment Management AB grew its position in HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after purchasing an additional 59,163 shares in the last quarter. Finally, LSV Asset Management boosted its stake in shares of HCA Healthcare by 0.4% during the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock worth $332,856,000 after buying an additional 3,396 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of several recent research reports. Truist Financial increased their price target on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Sanford C. Bernstein reissued a “market perform” rating and issued a $417.00 target price on shares of HCA Healthcare in a research note on Monday, October 27th. Oppenheimer increased their price target on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Bank of America upped their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a report on Monday, October 27th. Finally, KeyCorp boosted their price target on HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Fourteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $475.95.

HCA Healthcare Stock Up 0.5%

Shares of HCA stock opened at $484.67 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $520.00. The firm has a 50 day moving average price of $465.59 and a two-hundred day moving average price of $413.62. The company has a market capitalization of $110.60 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 1.42 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period last year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.